Predicting the impact of COVID-19 non-pharmaceutical intervention on short- and medium-term dynamics of enterovirus D68 in the US

Recent outbreaks of enterovirus D68 (EV-D68) infections, and their causal linkage with acute flaccid myelitis (AFM), continue to pose a serious public health concern. During 2020 and 2021, the dynamics of EV-D68 and other pathogens have been significantly perturbed by non-pharmaceutical intervention...

Full description

Bibliographic Details
Main Authors: Sang Woo Park, Kevin Messacar, Daniel C. Douek, Alicen B. Spaulding, C. Jessica E. Metcalf, Bryan T. Grenfell
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Epidemics
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1755436523000725
_version_ 1797267213962444800
author Sang Woo Park
Kevin Messacar
Daniel C. Douek
Alicen B. Spaulding
C. Jessica E. Metcalf
Bryan T. Grenfell
author_facet Sang Woo Park
Kevin Messacar
Daniel C. Douek
Alicen B. Spaulding
C. Jessica E. Metcalf
Bryan T. Grenfell
author_sort Sang Woo Park
collection DOAJ
description Recent outbreaks of enterovirus D68 (EV-D68) infections, and their causal linkage with acute flaccid myelitis (AFM), continue to pose a serious public health concern. During 2020 and 2021, the dynamics of EV-D68 and other pathogens have been significantly perturbed by non-pharmaceutical interventions against COVID-19; this perturbation presents a powerful natural experiment for exploring the dynamics of these endemic infections. In this study, we analyzed publicly available data on EV-D68 infections, originally collected through the New Vaccine Surveillance Network, to predict their short- and long-term dynamics following the COVID-19 interventions. Although long-term predictions are sensitive to our assumptions about underlying dynamics and changes in contact rates during the NPI periods, the likelihood of a large outbreak in 2023 appears to be low. Comprehensive surveillance data are needed to accurately characterize future dynamics of EV-D68. The limited incidence of AFM cases in 2022, despite large EV-D68 outbreaks, poses further questions for the timing of the next AFM outbreaks.
first_indexed 2024-03-08T21:51:29Z
format Article
id doaj.art-d8304b757a3a49cd8546a22a0c838893
institution Directory Open Access Journal
issn 1755-4365
language English
last_indexed 2024-04-25T01:13:01Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Epidemics
spelling doaj.art-d8304b757a3a49cd8546a22a0c8388932024-03-10T05:11:34ZengElsevierEpidemics1755-43652024-03-0146100736Predicting the impact of COVID-19 non-pharmaceutical intervention on short- and medium-term dynamics of enterovirus D68 in the USSang Woo Park0Kevin Messacar1Daniel C. Douek2Alicen B. Spaulding3C. Jessica E. Metcalf4Bryan T. Grenfell5Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA; Corresponding author.Department of Pediatrics, Section of Infectious Diseases, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO, USAVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USAVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USADepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA; Princeton School of Public and International Affairs, Princeton University, Princeton, NJ, USADepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA; Princeton School of Public and International Affairs, Princeton University, Princeton, NJ, USARecent outbreaks of enterovirus D68 (EV-D68) infections, and their causal linkage with acute flaccid myelitis (AFM), continue to pose a serious public health concern. During 2020 and 2021, the dynamics of EV-D68 and other pathogens have been significantly perturbed by non-pharmaceutical interventions against COVID-19; this perturbation presents a powerful natural experiment for exploring the dynamics of these endemic infections. In this study, we analyzed publicly available data on EV-D68 infections, originally collected through the New Vaccine Surveillance Network, to predict their short- and long-term dynamics following the COVID-19 interventions. Although long-term predictions are sensitive to our assumptions about underlying dynamics and changes in contact rates during the NPI periods, the likelihood of a large outbreak in 2023 appears to be low. Comprehensive surveillance data are needed to accurately characterize future dynamics of EV-D68. The limited incidence of AFM cases in 2022, despite large EV-D68 outbreaks, poses further questions for the timing of the next AFM outbreaks.http://www.sciencedirect.com/science/article/pii/S1755436523000725Enterovirus D68infectious disease moelingNon-pharmaceutical interventionCOVID- 19
spellingShingle Sang Woo Park
Kevin Messacar
Daniel C. Douek
Alicen B. Spaulding
C. Jessica E. Metcalf
Bryan T. Grenfell
Predicting the impact of COVID-19 non-pharmaceutical intervention on short- and medium-term dynamics of enterovirus D68 in the US
Epidemics
Enterovirus D68
infectious disease moeling
Non-pharmaceutical intervention
COVID- 19
title Predicting the impact of COVID-19 non-pharmaceutical intervention on short- and medium-term dynamics of enterovirus D68 in the US
title_full Predicting the impact of COVID-19 non-pharmaceutical intervention on short- and medium-term dynamics of enterovirus D68 in the US
title_fullStr Predicting the impact of COVID-19 non-pharmaceutical intervention on short- and medium-term dynamics of enterovirus D68 in the US
title_full_unstemmed Predicting the impact of COVID-19 non-pharmaceutical intervention on short- and medium-term dynamics of enterovirus D68 in the US
title_short Predicting the impact of COVID-19 non-pharmaceutical intervention on short- and medium-term dynamics of enterovirus D68 in the US
title_sort predicting the impact of covid 19 non pharmaceutical intervention on short and medium term dynamics of enterovirus d68 in the us
topic Enterovirus D68
infectious disease moeling
Non-pharmaceutical intervention
COVID- 19
url http://www.sciencedirect.com/science/article/pii/S1755436523000725
work_keys_str_mv AT sangwoopark predictingtheimpactofcovid19nonpharmaceuticalinterventiononshortandmediumtermdynamicsofenterovirusd68intheus
AT kevinmessacar predictingtheimpactofcovid19nonpharmaceuticalinterventiononshortandmediumtermdynamicsofenterovirusd68intheus
AT danielcdouek predictingtheimpactofcovid19nonpharmaceuticalinterventiononshortandmediumtermdynamicsofenterovirusd68intheus
AT alicenbspaulding predictingtheimpactofcovid19nonpharmaceuticalinterventiononshortandmediumtermdynamicsofenterovirusd68intheus
AT cjessicaemetcalf predictingtheimpactofcovid19nonpharmaceuticalinterventiononshortandmediumtermdynamicsofenterovirusd68intheus
AT bryantgrenfell predictingtheimpactofcovid19nonpharmaceuticalinterventiononshortandmediumtermdynamicsofenterovirusd68intheus